| Product Code: ETC9952751 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Precision Oncology Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Precision Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Precision Oncology Market - Industry Life Cycle |
3.4 United Kingdom (UK) Precision Oncology Market - Porter's Five Forces |
3.5 United Kingdom (UK) Precision Oncology Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United Kingdom (UK) Precision Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 United Kingdom (UK) Precision Oncology Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 United Kingdom (UK) Precision Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the United Kingdom |
4.2.2 Technological advancements in precision oncology treatments |
4.2.3 Rising investments in research and development in the oncology sector |
4.3 Market Restraints |
4.3.1 High costs associated with precision oncology treatments |
4.3.2 Regulatory challenges and approval processes for new precision oncology therapies |
5 United Kingdom (UK) Precision Oncology Market Trends |
6 United Kingdom (UK) Precision Oncology Market, By Types |
6.1 United Kingdom (UK) Precision Oncology Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Precision Oncology Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Precision Oncology Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.4 United Kingdom (UK) Precision Oncology Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.2 United Kingdom (UK) Precision Oncology Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Precision Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 United Kingdom (UK) Precision Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.4 United Kingdom (UK) Precision Oncology Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.2.5 United Kingdom (UK) Precision Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.6 United Kingdom (UK) Precision Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.7 United Kingdom (UK) Precision Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Precision Oncology Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Precision Oncology Market Revenues & Volume, By Hospitals & Diagnostic Laboratories, 2021- 2031F |
6.3.3 United Kingdom (UK) Precision Oncology Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.4 United Kingdom (UK) Precision Oncology Market Revenues & Volume, By Healthcare Data Companies, 2021- 2031F |
7 United Kingdom (UK) Precision Oncology Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Precision Oncology Market Export to Major Countries |
7.2 United Kingdom (UK) Precision Oncology Market Imports from Major Countries |
8 United Kingdom (UK) Precision Oncology Market Key Performance Indicators |
8.1 Average cost per patient for precision oncology treatment |
8.2 Number of clinical trials and studies focused on precision oncology in the UK |
8.3 Adoption rate of precision oncology techniques in cancer treatment centers |
9 United Kingdom (UK) Precision Oncology Market - Opportunity Assessment |
9.1 United Kingdom (UK) Precision Oncology Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United Kingdom (UK) Precision Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 United Kingdom (UK) Precision Oncology Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 United Kingdom (UK) Precision Oncology Market - Competitive Landscape |
10.1 United Kingdom (UK) Precision Oncology Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Precision Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here